Clinical Trials

Melanoma

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 5 of 5 Clinical Trials Related to Melanoma

Nektar 20-214-29 PIVOT 12 Melanoma study

20-214-29 / CA045-022: A Phase 3, Randomized, Open-label Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined with Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk

...
Doctor(s) Running This Study
Suresh G. Nair, MD

BMS CA 209-76K Melanoma

A Phase 3, Randomized, Double-Blind Study of Adjuvant Immunotherapy with Nivolumab versus Placebo after Complete Resection of Stage IIB/C Melanoma

...
Doctor(s) Running This Study
Suresh G. Nair, MD

SWOG S1801 Melanoma

A Phase II Randomized Study of Adjuvant Versus Neoadjuvant MK-3475 (Pembrolizumab) for Clinically Detectable Stage III-IV High Risk Melanoma

...
Doctor(s) Running This Study
Maged F. Khalil, MD

BMS-047 Melanoma

A Randomized, Double-Blind Phase 2/3 Study of Relatlimab Combined with Nivolumab versus Nivolumab in Participants with Previously Untreated Metastatic or Unresectable Melanoma

 

...
Doctor(s) Running This Study
Suresh G. Nair, MD

BMS-020 Melanoma

A Phase 1/2a Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (BMS-986016) Administered Alone and in Combination with Anti-PD-1 Monoclonal Antibody (Nivolumab

...
Doctor(s) Running This Study
Suresh G. Nair, MD